Elanco’s stock heads for 18-month high as company sells aqua business to Merck for $1.3 billion in cash
The deal “allows us to prioritize our investments in larger markets with greater earnings potential over the medium and long term, while creating balance sheet flexibility.”
The deal “allows us to prioritize our investments in larger markets with greater earnings potential over the medium and long term, while creating balance sheet flexibility.”
